2-Arahidonilgliceril etar (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "2-Arahidonilgliceril etar" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
149th place
283rd place
low place
low place
archive.org
- Shoemaker JL, Joseph BK, Ruckle MB, Mayeux PR, Prather PL (2005). „The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors”. J. Pharmacol. Exp. Ther. 314 (2): 868—75. PMID 15901805. doi:10.1124/jpet.105.085282.
- Duncan M, Millns P, Smart D, Wright JE, Kendall DA, Ralevic V (2004). „Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 Gi/o linked receptor”. Br. J. Pharmacol. 142 (3): 509—18. PMC 1574960
. PMID 15148262. doi:10.1038/sj.bjp.0705789. - Laine K, Järvinen K, Mechoulam R, Breuer A, Järvinen T (2002). „Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid”. Invest. Ophthalmol. Vis. Sci. 43 (10): 3216—22. PMID 12356827.
- Sun Y; Alexander SP; Garle MJ; et al. (2007). „Cannabinoid activation of PPARα; a novel neuroprotective mechanism”. Br. J. Pharmacol. 152 (5): 734—43. PMC 2190030 . PMID 17906680. doi:10.1038/sj.bjp.0707478.
doi.org
- Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- Hanus, L.; Abu-Lafi, S.; Fride, E.; Breuer, A.; Vogel, Z.; Shalev, D.; Kustanovich, I.; Mechoulam, R. (2001). „2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor”. Proceedings of the National Academy of Sciences. 98 (7): 3662—3665. PMC 31108 . PMID 11259648. doi:10.1073/pnas.061029898.
- Shoemaker JL, Joseph BK, Ruckle MB, Mayeux PR, Prather PL (2005). „The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors”. J. Pharmacol. Exp. Ther. 314 (2): 868—75. PMID 15901805. doi:10.1124/jpet.105.085282.
- Duncan M, Millns P, Smart D, Wright JE, Kendall DA, Ralevic V (2004). „Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 Gi/o linked receptor”. Br. J. Pharmacol. 142 (3): 509—18. PMC 1574960 . PMID 15148262. doi:10.1038/sj.bjp.0705789.
- Shoemaker JL, Ruckle MB, Mayeux PR, Prather PL (2005). „Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors”. J. Pharmacol. Exp. Ther. 315 (2): 828—38. PMID 16081674. doi:10.1124/jpet.105.089474.
- Venderova K, Brown TM, Brotchie JM (2005). „Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus”. Exp. Neurol. 194 (1): 284—7. PMID 15899265. doi:10.1016/j.expneurol.2005.02.012.
- Sun Y; Alexander SP; Garle MJ; et al. (2007). „Cannabinoid activation of PPARα; a novel neuroprotective mechanism”. Br. J. Pharmacol. 152 (5): 734—43. PMC 2190030 . PMID 17906680. doi:10.1038/sj.bjp.0707478.
nih.gov
ncbi.nlm.nih.gov
- Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- Hanus, L.; Abu-Lafi, S.; Fride, E.; Breuer, A.; Vogel, Z.; Shalev, D.; Kustanovich, I.; Mechoulam, R. (2001). „2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor”. Proceedings of the National Academy of Sciences. 98 (7): 3662—3665. PMC 31108 . PMID 11259648. doi:10.1073/pnas.061029898.
- Shoemaker JL, Joseph BK, Ruckle MB, Mayeux PR, Prather PL (2005). „The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors”. J. Pharmacol. Exp. Ther. 314 (2): 868—75. PMID 15901805. doi:10.1124/jpet.105.085282.
- Duncan M, Millns P, Smart D, Wright JE, Kendall DA, Ralevic V (2004). „Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 Gi/o linked receptor”. Br. J. Pharmacol. 142 (3): 509—18. PMC 1574960 . PMID 15148262. doi:10.1038/sj.bjp.0705789.
- Shoemaker JL, Ruckle MB, Mayeux PR, Prather PL (2005). „Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors”. J. Pharmacol. Exp. Ther. 315 (2): 828—38. PMID 16081674. doi:10.1124/jpet.105.089474.
- Laine K, Järvinen K, Mechoulam R, Breuer A, Järvinen T (2002). „Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid”. Invest. Ophthalmol. Vis. Sci. 43 (10): 3216—22. PMID 12356827.
- Venderova K, Brown TM, Brotchie JM (2005). „Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus”. Exp. Neurol. 194 (1): 284—7. PMID 15899265. doi:10.1016/j.expneurol.2005.02.012.
- Sun Y; Alexander SP; Garle MJ; et al. (2007). „Cannabinoid activation of PPARα; a novel neuroprotective mechanism”. Br. J. Pharmacol. 152 (5): 734—43. PMC 2190030 . PMID 17906680. doi:10.1038/sj.bjp.0707478.
sciencedirect.com
- Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
wikipedia.org
sr.wikipedia.org
- Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.